Posch Florian, Riedl Julia, Reitter Eva-Maria, Crowther Michael J, Grilz Ella, Quehenberger Peter, Jilma Bernd, Pabinger Ingrid, Ay Cihan
Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
J Thromb Haemost. 2020 Jun;18(6):1348-1356. doi: 10.1111/jth.14774. Epub 2020 Apr 15.
Venous thromboembolism (VTE) is a frequent complication of cancer. Elevated D-dimer is associated with an increased risk of cancer-associated VTE. Whether changes in D-dimer over time harbor additional prognostic information that may be exploited clinically for dynamic prediction of VTE is unclear.
To explore the potential role of longitudinal D-dimer trajectories for personalized prediction of cancer-associated VTE.
PATIENTS/METHODS: A total of 167 patients with active malignancy were prospectively enrolled (gastrointestinal: n = 59 [35%], lung: n = 56 [34%], brain: n = 50 [30%], others: n = 2 [1%]; metastatic disease: n = 74 [44%]). D-dimer (median = 0.8 µg/mL [25th-75th percentile: 0.4-2.0]) was measured at baseline and during 602 monthly follow-up visits. Joint models of longitudinal and time-to-event data were implemented to quantify the association between D-dimer trajectories and prospective risk of VTE.
VTE occurred in 20 patients (250-day VTE risk = 12.1%, 95% confidence interval [CI], 7.8-18.5). D-dimer increased by 34%/month (0.47 µg/mL/month, 95% CI, 0.22-0.72, P < .0001) in patients who developed VTE, but remained constant in patients who did not develop VTE (change/month = -0.06 µg/mL, 95% CI, -0.15 to 0.02, P = .121). In joint modeling, a doubling of the D-dimer trajectory was associated with a 2.8-fold increase in the risk of VTE (hazard ratio = 2.78, 95% CI, 1.69-4.58, P < .0001). This finding was independent of established VTE risk factors. Highly personalized, dynamic predictions of VTE conditional on individual patients' D-dimer trajectories could be obtained.
D-dimer increases before the onset of cancer-associated VTE, but remains constant over time in patients without VTE. This study represents proof-of-concept that longitudinal trajectories of D-Dimer may advance the personalized assessment of VTE risk in the oncologic setting.
静脉血栓栓塞症(VTE)是癌症常见的并发症。D - 二聚体升高与癌症相关VTE风险增加有关。D - 二聚体随时间的变化是否包含可用于临床动态预测VTE的额外预后信息尚不清楚。
探讨D - 二聚体纵向轨迹在个性化预测癌症相关VTE中的潜在作用。
患者/方法:前瞻性纳入167例活动性恶性肿瘤患者(胃肠道:n = 59 [35%],肺癌:n = 56 [34%],脑癌:n = 50 [30%],其他:n = 2 [1%];转移性疾病:n = 74 [44%])。在基线及602次每月随访中测量D - 二聚体(中位数 = 0.8 μg/mL [第25 - 75百分位数:0.4 - 2.0])。采用纵向和事件发生时间数据的联合模型来量化D - 二聚体轨迹与VTE前瞻性风险之间的关联。
20例患者发生VTE(250天VTE风险 = 12.1%,95%置信区间[CI],7.8 - 18.5)。发生VTE的患者中D - 二聚体每月增加34%(0.47 μg/mL/月,95% CI,0.22 - 0.72,P <.0001),而未发生VTE的患者中D - 二聚体保持不变(每月变化 = -0.06 μg/mL,95% CI,-0.15至0.02,P =.121)。在联合建模中,D - 二聚体轨迹翻倍与VTE风险增加2.8倍相关(风险比 = 2.78,95% CI,1.69 - 4.58,P <.0001)。这一发现独立于已确定的VTE风险因素。可根据个体患者的D - 二聚体轨迹获得高度个性化的VTE动态预测。
癌症相关VTE发作前D - 二聚体升高,但无VTE的患者中D - 二聚体随时间保持不变。本研究证明了D - 二聚体的纵向轨迹可能推进肿瘤环境中VTE风险的个性化评估这一概念。